Coil assisted flow diverter is an adjunctive intrasaccular stent made of super visible braid elastic matter and is less restrictive. It is designed for the placement of embolization coils in the treatment of aneurysms. Coil assisted flow diverter also possesses mesh braid of contour neurovascular system, with memory properties, self-anchoring, stabilizing and less restricting sizing with the help of high precision re-sheathable placement into the aneurysm sac neck. The growth of the coil assisted flow diverters market is attributed to the factors such as rising incidence of intracranial aneurysms and growing incidence of hypertension, obesity, smoking, and alcoholism. However, the high cost of neurosurgical devices hinders the market growth.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Coil Assisted Flow Diverters Market: Strategic Insights
Coil assisted flow diverters are stent-like devices used for the embolization of intracranial aneurysms. The incidence of intracranial aneurysms is increasing across the world. For instance, the Brain Aneurysm Foundation, Statistics and Facts report stated that around 6.5 million people (that is 1 in 50 people) in the US have an unruptured brain aneurysm. The report has also mentioned that 20% of the total people diagnosed with a brain aneurysm have more than one aneurysm. It has further reported that, every year, around 30,000 people in the US suffer from a brain aneurysm rupture, and a brain aneurysm rupture takes place in every 18 minutes. Also, Brain Aneurysm Foundation of Canada reported that about 8 to 10 people in 100,000, or around 2,800 to 3,500 Canadians, suffer from a burst aneurysm every year, which accounts for about 3% of all hemorrhagic strokes. Further, as per the National Health Service (NHS), 1 in 12,500 people have a ruptured brain aneurysm in England each year. Additionally, as per the ‘Unruptured Intracranial Aneurysms—Pathogenesis and Individualized Management’ report published in Deutsches Ärzteblatt International in 2020, around 2 million adults in Germany have an unruptured intracranial aneurysm (IA). Thus, the increasing prevalence of intracranial aneurysms drives the growth of the coil assisted flow diverters market.
The coil assisted flow diverters market, by application, is bifurcated into wide-neck bifurcation aneurysms and narrow neck bifurcation aneurysms. The wide-neck bifurcation aneurysms segment held a larger market share in 2021, and the same segment is anticipated to register a higher CAGR in the market during the forecast period.
End User -Based Insights
The coil assisted flow diverters market, by end user, is segmented into hospitals, clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the market in 2021. Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, players operating in the coil assisted flow diverters market focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world.
The regional trends and factors influencing the Coil Assisted Flow Diverters Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Coil Assisted Flow Diverters Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 278.23 Million |
| Market Size by 2028 | US$ 465.85 Million |
| Global CAGR (2021 - 2028) | 7.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Application
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Coil Assisted Flow Diverters Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Coil Assisted Flow Diverters Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The List of Companies - Coil Assisted Flow Diverters Market
The growth of the region is attributed to factors such as rising public–private partnerships, and increasing funding activities are widely enhancing the performance of medical devices Moreover, presence of well-developed healthcare infrastructure and government support are some of the prominent factors propelling the market growth in Asia Pacific. In addition, the North America is expected account for the fastest growth in the coil assisted flow diverters market. A high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of medical device growth of coil assisted flow diverters market during the forecast period.
Coil assisted flow diverters is an adjunctive intrasaccular stent which is made of super visible braid elastic matter and is less restrictive .It is designed for application with embolization coils for the treatment of aneurysms. It also possesses mesh braid of contour neurovascular system, with memory properties, self-anchoring, stabilizing and less restricting sizing with the help of high precision re-sheathable placement into the aneurysm sac neck.
The growth of the market is attributed to some key driving factors such as the rising incidence of intracranial aneursyms, growing incidence of hypertension, smoking, alcoholism, and obesity. For instance, In December 2020, Terumo Corporation launched WEB Embolization System (Product name in Japan: Woven EndoBridge Device), an intrasaccular aneurysm treatment device, in Japan. The WEB device is an innovative intrasaccular flow disruptor device and provides new treatment options for brain aneurysm cases. Such strategic steps are also projected to drive the market growth.